WG
William Grossman bought $10K of ENGN stock
William Grossman, Interim Chief Medical Officer of enGene Therapeutics Inc. (ENGN), bought 5,102 shares of ENGN stock worth $10K, per an SEC Form 4 filed Sep 24, 2026.
It was an open-market purchase.
The trade happened on Sep 22, 2026, 2 days before it was made public.
ENGN has moved -14.6% since the trade date, from $2.05 to $1.75 (Nov 6, 2026 close).
- Traded
- Sep 22, 2026
- Disclosed
- Sep 24, 2026
- Filing delay
- 2 days
- Price since
- -14.6%
- Role
- Interim Chief Medical Officer
- Source
- SEC Form 4